全文获取类型
收费全文 | 29229篇 |
免费 | 1856篇 |
国内免费 | 655篇 |
专业分类
耳鼻咽喉 | 148篇 |
儿科学 | 645篇 |
妇产科学 | 425篇 |
基础医学 | 2048篇 |
口腔科学 | 267篇 |
临床医学 | 3869篇 |
内科学 | 8060篇 |
皮肤病学 | 105篇 |
神经病学 | 395篇 |
特种医学 | 1116篇 |
外科学 | 8365篇 |
综合类 | 3356篇 |
现状与发展 | 1篇 |
预防医学 | 816篇 |
眼科学 | 255篇 |
药学 | 1327篇 |
19篇 | |
中国医学 | 233篇 |
肿瘤学 | 290篇 |
出版年
2024年 | 57篇 |
2023年 | 634篇 |
2022年 | 1150篇 |
2021年 | 1633篇 |
2020年 | 1584篇 |
2019年 | 1463篇 |
2018年 | 1375篇 |
2017年 | 981篇 |
2016年 | 897篇 |
2015年 | 1005篇 |
2014年 | 2160篇 |
2013年 | 2063篇 |
2012年 | 1383篇 |
2011年 | 1668篇 |
2010年 | 1322篇 |
2009年 | 1340篇 |
2008年 | 1268篇 |
2007年 | 1235篇 |
2006年 | 1136篇 |
2005年 | 973篇 |
2004年 | 845篇 |
2003年 | 727篇 |
2002年 | 638篇 |
2001年 | 519篇 |
2000年 | 454篇 |
1999年 | 382篇 |
1998年 | 320篇 |
1997年 | 285篇 |
1996年 | 251篇 |
1995年 | 236篇 |
1994年 | 225篇 |
1993年 | 187篇 |
1992年 | 185篇 |
1991年 | 119篇 |
1990年 | 117篇 |
1989年 | 102篇 |
1988年 | 102篇 |
1987年 | 108篇 |
1986年 | 96篇 |
1985年 | 95篇 |
1984年 | 79篇 |
1983年 | 55篇 |
1982年 | 74篇 |
1981年 | 38篇 |
1980年 | 36篇 |
1979年 | 38篇 |
1978年 | 28篇 |
1976年 | 22篇 |
1975年 | 15篇 |
1973年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
111.
组织工程心脏瓣膜研究进展 总被引:1,自引:0,他引:1
目前组织工程心脏瓣膜研究已在支架的选材、种子细胞的选择、种子细胞的种植与瓣膜构建方法三个方面取得进展,并已构建出三种代表性组织工程心脏瓣膜。对它们各自的特点进行综述。 相似文献
112.
James L Onambele G Woledge R Skelton D Woods D Eleftheriou K Hawe E Humphries SE Haddad F Montgomery H 《European journal of applied physiology》2004,92(1-2):227-230
A reduction in interleukin-6 (IL-6) activity may contribute to the beneficial effects of hormone replacement therapy (HRT) on the menopausal decline in bone mineral density (BMD). We have examined this hypothesis using a genetic strategy. The –174C (rather than G) IL-6 gene variant is associated with lower IL-6 expression. As such, we might anticipate the C allele to be associated with a greater response to HRT. We have tested this hypothesis. Mean three-site [spine (L1-L4), neck of femur, and Wards triangle] BMD was measured in 65 women in a 1-year randomised controlled trial of HRT with 0.625 mg oestrogen/day and 0.15 mg norgestrel (n=30). Baseline BMD was genotype-independent for both the control and HRT group. In the control group, the percentage change in BMD after 1 year was similar between genotypes (P=0.45). In contrast, in the HRT group, the rise was genotype-dependent. Those homozygous for the G allele showed a 3.62 (2.14)% increase in BMD compared with 10.44 (4.68)% for the C-homozygous group. Heterozygotes had an intermediate BMD increase of 5.6 (2.82)% [P=0.006 (P value for interaction between HRT and genotype was 0.04)] Although the study was limited by its small sample size, these are the first data to demonstrate the importance of IL-6 genotype in determining response to oestrogen therapy, rather than its physiological withdrawal. 相似文献
113.
Alberto Bacchi-Modena Pierfrancesco Bolis Carlo Campagnoli Fiorenzo De Cicco Michele Meschia Francesco Pansini Roberto Pisati Gabriele Hüls 《Maturitas》1997,27(3):285-292
Objectives: To assess the efficacy and tolerability of a new matrix patch delivering 0.05 mg estradiol per day (Estraderm MX 50) in postmenopausal women with moderate to severe postmenopausal symptoms. Methods: A multicenter, double-blin, randomized, between-patient, placebo controlled trial in 109 postmenopausal women was carried out. Patches were applied twice weekly for 12 weeks. Patients were assessed at 4, 8 and 12 weeks of treatment. The primary efficacy variable was change from baseline in mean number of moderate to severe hot flushes (including night sweats) per 24 h during the last 2 weeks of treatment. Other variables included Kupperman Index, local and systemic tolerability. Plasma concentrations of estradiol (E2), estrone (E1) and estrone sulfate (E1S) were determined before and after treatment. Results: Estraderm MX was significantly superior to placebo (P < 0.001) in reducing mean number of moderate to severe hot flushes (including night sweats) per 24 h after 4, 8 and 12 weeks of treatment. The estimate of treatment group differences after 12 weeks was 4.2 hot flushes (95% confidence interval: 2.6–5.5). Estraderm MX also significantly reduced Kupperman Index at all time points compared to placebo (P < 0.001). Estraderm MX induced increases in mean E2, E1 and E1S plasma levels as expected (E2: baseline 2.7 pg/ml, 12 weeks 38.9 pg/ml; E1: baseline 18.8 pg/ml, 12 weeks 41.6 pg/ml; E1S: baseline 235.6 pg/ml, 12 weeks 765.1 pg/ml). Overall rates of adverse experiences were similar for Estraderm MX and placebo. The number of patients reporting skin irritation was low and similar in both groups. Conclusions: Estraderm MX 50, a new matrix patch, offers an effective and well tolerated dosage form for transdermal delivery of 0.05 mg E2 per day. 相似文献
114.
自行设计和制造平面和三维立体培养室及贮液室等构件,用医用硅胶管连接;转子泵作为动力源,贮液室通气口供给5%CO2 95%空气,恒温水浴箱保持构件37℃恒温,这样组成了种植细胞与生物瓣支架复合体的脉动培养系统,并进行生物力学和生物相容性测试,为心脏组织工程瓣的体外构建提供研究器材。结果显示,该装置密闭性能好,内环境能保持37±1℃、CO2浓度5%±1%、pH值6.8~7.5;流量在0.125~6.0L/min的范围内任意调节;同种瓣膜上的内皮细胞经2周培养后扩增约10倍;瓣膜支架的细菌和霉菌培养均为阴性,说明我们构建的脉动流培养系统能有效地模拟体内脉动流场实现种植细胞在体外的增殖、重塑,为心脏组织工程瓣的体外构建提供了一种新的实验方法。 相似文献
115.
Y. Misawa T. Saito H. Konishi S. Oki Y. Kaminishi K. Aizawa H. Takahashi O. Kamisawa M. Kato K. Fuse 《Journal of artificial organs》2002,5(3):0184-0187
We discuss the usefulness of the Cosgrove-Edwards ring from our early clinical results from 25 rings in 24 patients who underwent
mitral annuloplasty (MAP) or tricuspid annuloplasty (TAP) between June 1999 and December 2000. In the MAP group, the posterior
mitral annulus between the anterior and posterior fibrous trigones was reinforced with the prosthetic ring. In the TAP group,
the annuli of the anterior and posterior leaflets were splinted with the ring. The prosthetic ring was attached by pledgeted
U-sutures. Cardiologists performed echocardiography pre- and postoperatively. Thirteen of the 14 in the MAP group showed mitral
valve regurgitation of grade 0 or I. Six of the 11 in the TAP group showed tricuspid regurgitation of grade 0 or I, and 5
patients with regurgitation equal to or greater than grade II who remained in atrial fibrillation postoperatively recovered
without further clinical symptoms. No patient has required reoperation during a follow-up period of up to 2 years. Cosgrove-Edwards
ring-related complications, such as valve stenosis, ring detachment, and arrhythmia, have been not recognized in these patients.
In conclusion, for mitral and tricuspid annuloplasty, the Cosgrove-Edwards prosthetic ring showed excellent early clinical
results, particularly in patients maintained in sinus rhythm.
Received: November 5, 2001 / Accepted: May 30, 2002
Correspondence to:Y. Misawa 相似文献
116.
117.
目的 观测家猪心脏三尖瓣复合体 ,为家猪心脏研究和心脏移植积累资料。方法 甲醛固定的家猪心脏 35例 ,大体解剖并观测三尖瓣复合体。结果 家猪心脏三尖瓣复合体由瓣环、瓣膜、腱索和乳头肌构成 ,瓣环周长为 70 75± 8 4 5mm ,前瓣、后瓣、隔侧瓣、前隔连合、前后连合、后隔连合的高度分别为 14 5 8±2 6 4、14 16± 2 5 0、12 84± 2 37、6 2 9± 1 97、6 86± 1 0 1、6 5 1± 1 36mm。前隔连合、前后连合、后隔连合的宽度分别为 6 4 0± 1 5 4、6 78± 1 2 3、6 4 3± 1 4 6 ;前乳头肌起始 ,腱索附着于前瓣、后瓣和前后连合的条数分别为 3 0 0± 0 97、3 0 9± 1 0 9、2 4 4± 1 16 ;后乳肌起始 ,腱索附着于后瓣、隔侧瓣和后隔连合的条数分别为 2 6 0± 0 6 9、3 0 9± 1 6 3、1 14± 0 4 3。隔侧乳头肌起始 ,附着于前瓣、隔侧瓣、前隔连合的腱索条数分别为1 71± 0 6 7、2 37± 1 2 6、0 94± 0 4 2。结论 家猪心脏三尖瓣复合体中各结构与人类相似 ,但大小有一定差异。 相似文献
118.
A new one-step computational procedure is presented for estimating the parameters of the nonlinear three-element windkessel
model of the arterial system incorporating a pressure-dependent compliance. The data required are pulsatile aortic pressure
and flow. The basic assumptions are a steadystate periodic regime and a purely elastic compliant element. By stating two conditions,
zero mean flow and zero mean power in the compliant element, peripheral and characteristic resistances are determined through
simple closed form formulas as functions of mean values of the square of aortic pressure, the square of aortic flow, and the
product of aortic pressure with aortic flow. The pressure across as well as the flow through the compliant element can be
then obtained so allowing the calculation of volume variation and compliance as functions of pressure. The feasibility of
this method is studied by applying it to both simulated and experimental data relative to different circulatory conditions
and comparing the results with those obtained by an iterative parameter optimization algorithm and with the actual values
when available. The conclusion is that the proposed method appears to be effective in identifying the three-element windkessel
even in the case of nonlinear compliance. 相似文献
119.
Marius J. van der Mooren Antonius G. J. M. Hanselaar George F. Borm Rune Rolland 《Maturitas》1994,20(2-3):175-180
Objective: To describe changes in the withdrawal bleeding pattern and endometrial histology during a sequential 17β-estradiol —dydrogesterone regimen in postmenopausal women. Design: Open-label, non-comparative, prospective study. Setting: Gynecological outpatient department of a university hospital. Patients: Twenty-seven healthy nonhysterectomized postmenopausal women. Interventions: Continuous micronized 17β-estradiol supplementation, 2 mg daily, and cyclic administration of dydrogesterone, 10 mg daily for the first half of each 28 day treatment cycle. Main Outcome Measures: Changes in the characteristics of the withdrawal bleeding pattern and the endometrial biopsy histology during 2 years of treatment. Results: The initial withdrawal bleeding was comparable to normal menstruation with respect to amount and duration. During the 2 years of treatment the bleeding showed a significant tendency to become shorter with less blood loss. This was mainly the result of the decrease (P < 0.001) in the number of days per cycle with bleeding grade II (normal menstruation). None of the women developed endometrial hyperplasia, and in almost all women the given hormone replacement therapy regimen induced secretory or atrophic changes of the endometrium. Conclusions: This sequential 17β-estradiol —dydrogesterone regimen can be regarded as safe with respect to the prevention of endometrial disease and appeared to foster patient compliance. 相似文献
120.
Shigemitsu Iwai MD Kei Torikai MD Chris M. Coppin MD Yoshiki Sawa MD 《Journal of artificial organs》2007,10(1):29-35
Currently used bioprosthetic valves have several limitations such as calcification and functional deterioration, and revitalization
through cellular ingrowth is impossible. To overcome these obstacles, we have developed a minimally immunogenic tissue-engineered
valve that consists of an unfixed, decellularized porcine valve scaffold capable of being spontaneously revitalized in vivo
after implantation. Porcine aortic root tissue was decellularized using detergents such as sodium lauryl sulfate and Triton
X-100. The porcine valve was treated very gently and plenty of time was allowed for constituents to diffuse in and out of
the matrix. In a preliminary study, a piece of decellularized porcine valve tissue was implanted into the rat subdermal space
for 14 and 60 days and the structural integrity and calcification were evaluated. As an in vivo valve replacement model, the
decellularized porcine valve was implanted in the pulmonary valve position in dogs and functional and histological evaluation
was performed after 1, 2, and 6 months. Histological examination showed that the newly developed detergent treatment effectively
removed cellular debris from the porcine aortic tissue. Decellularized porcine valve tissue implanted subdermally in rats
showed minimal inflammatory cell infiltration and calcification. In the valve replacement model, spontaneous reendothelialization
and repopulation of the medial cells were observed within 2 months, and good valve function without regurgitation was observed
by echocardiography up to 6 months. The minimally immunogenic decellularized porcine valve proved effective in mitigating
postimplant calcification and provided a suitable matrix for revitalizing prostheses through in situ recellularization, cellular
ingrowth, and tissue remodeling. 相似文献